Catalog #TR60
Tirzepatide
60 MG
Select Size:
Select Research Tier:
Batch-tested · Research-grade purity · Certificate of Analysis included
Quantity:
Line Total:
$140.00
Related Laboratory Supply
Laboratory Research Diluent — 0.9% Benzyl Alcohol is available separately for qualified laboratory workflows. Research use only. Not for human or animal use. Not for injection, diagnostic, clinical, therapeutic, or veterinary use.
View Laboratory Research Diluent →Technical Research Description
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. It contains a C20 fatty diacid moiety enabling extended duration of action. The molecule demonstrates 5:1 GIP:GLP-1 receptor binding affinity ratio, providing unique dual-pathway activation in metabolic research.
Simplified Explanation
This is a "twincretin" compound that activates two different hormone receptors at once - GIP and GLP-1. Unlike single-target peptides, it can trigger multiple metabolic pathways simultaneously. Scientists study how this dual-action affects cellular metabolism differently than activating just one pathway.
For Research Use Only
DISCLAIMER: This product is sold for research purposes only. Not for human consumption.
By purchasing, you confirm that you are a qualified researcher or represent a research institution, and that this product will be used solely for in-vitro research or lawful scientific study.
Certificate of Analysis (COA)
THIRD-PARTY VERIFIEDIndependent third-party HPLC and mass spectrometry analysis is provided for every batch.
Customer Reviews
No reviews yet — be the first to share your experience.
Frequently bought together
From Our Research Blog
Background reading and laboratory context for Tirzepatide 60 MG — sourced from our research articles.
research
Tirzepatide: A dual incretin tool for metabolic work
Tirzepatide is a dual GIP/GLP-1 receptor agonist used in preclinical metabolic studies. Here's what to measure, control, and compa…
Jul 16, 2026
research
Tirzepatide: perspectivas mecanísticas en investigación metabólica preclínica
Resumen científico de tirzepatide como agonista dual GIP/GLP-1 en investigación metabólica. Mecanismos, biomarcadores y diseño exp…
Jun 10, 2026
research
Tirzepatide Research Spotlight: Dual Incretin Signaling Mechanisms
Explore tirzepatide research on dual GIP/GLP-1 receptor signaling, metabolic pathways, and experimental design considerations for …
Jun 10, 2026
research
Tirzepatide dual receptor mechanism: why it matters
A research-first tour of tirzepatide's GIP/GLP-1 agonism: signaling bias, beta-cell effects, appetite circuits, and experimental d…
Aug 3, 2026
research
"WOLVERINE" BPC-157 + TB-500: Combo Rationale
A research-first look at why pairing BPC-157 and TB-500 shows up in repair biology literature, plus practical readouts for lab stu…
Jul 29, 2026
research
LC-120 Lipotropic Research Blend for Hepatic Lipid Flux
LC-120 is a ready-to-use lipotropic blend for in-vitro work on hepatic lipid transport, choline metabolism, and methionine-cycle b…
Jul 23, 2026
